摘要
目的分析不同剂量质子泵抑制剂(PPI)序贯疗法治疗幽门螺杆菌(Hp)阳性消化性溃疡的临床效果及安全性。方法选取2017年1月至2018年5月上海市嘉定区南翔医院收治的Hp阳性消化性溃疡患者80例,采用随机数表法分为常规剂量组和大剂量组,每组40例,常规剂量组予以常规剂量的PPI序贯疗法治疗,大剂量组予以大剂量PPI序贯疗法治疗,疗程均为10 d。治疗结束后,通过消化性溃疡疗效评判标准进行疗效判定,疗程结束4周后通过14C-尿素呼气试验评定Hp清除效果,分别于治疗前及治疗后评价临床症状积分,记录症状消失时间、不良反应以及随访6个月后的复发情况。结果治疗后,常规剂量组患者的治疗总有效率为90.00%,与大剂量组的92.50%比较差异无统计学意义(P>0.05);疗程结束后4周,常规剂量组与大剂量组患者的Hp清除率分别为95.00%,87.50%,差异无统计学意义(P>0.05);疗程结束后,两组患者的临床症状积分、临床症状缓解时间、不良反应发生率比较,差异均无统计学意义(P>0.05);随访6个月,常规剂量组与大剂量组复发率分别为6.98%、10.00%,差异无统计学意义(P>0.05)。结论在Hp阳性消化性溃疡患者治疗中常规剂量与大剂量PPI序贯疗法相比,临床疗效及安全性相当。
Objective To analyze the clinical effect and safety of sequential therapy with different doses of proton pump inhibitor(PPI) in the treatment of Helicobacter pylori(Hp)-positive peptic ulcer. Methods Eighty patients with Hp-positive peptic ulcer admitted to Nanxiang Hospital of Jiading District of Shanghai from January 2017 to May2018 were randomly divided into conventional dose group and high dose group, with 40 patients in each group. The conventional dose group was treated with conventional dose PPI sequential therapy, while the high dose group was treated with high dose PPI sequential therapy for 10 days. After the treatment, the curative effect was determined by the curative effect evaluation standard of peptic ulcer. Four weeks after the treatment, the Hp clearance effect was evaluated by14 Curea breath test. The clinical symptom scores were evaluated before and after the treatment, and the symptom disappearance time, adverse reactions and recurrence after 6 months of follow-up were recorded. Results After treatment, the total effective rate in conventional dose group was 90.00%, and there was no significant difference as compared with92.50% in high dose group(P>0.05). Four weeks after the treatment, Hp clearance rates of patients in conventional dose group and high dose group were 95.00% and 87.50%, respectively, with no significant difference between the two groups(P>0.05). After the treatment, there was no significant difference between the two groups in clinical symptom scores, clinical symptom relief time, and incidence of adverse reactions(P>0.05). Follow-up for 6 months showed that the recurrence rates of conventional dose group and high dose group were 6.98% and 10.00%, respectively, with no significant difference between the two groups(P>0.05). Conclusion In the treatment of Hp-positive peptic ulcer patients,the clinical efficacy and safety of conventional dose is equivalent to that of high dose PPI sequential therapy.
作者
顾海莺
陆敏
叶玲珠
GU Hai-ying;LU Min;YE Ling-zhu(GI Medicine,the Nanxiang Hospital of Jiading District of Shanghai,Shanghai 201802,CHINA;Department of General Practice,Community Health Service Center of Jiading Town Street,Jiading District,Shanghai,Shanghai 201803,CHINA)
出处
《海南医学》
CAS
2019年第23期2996-2999,共4页
Hainan Medical Journal
基金
上海市嘉定区卫健委科研项目(编号:2018-KY-06)
关键词
消化性溃疡
幽门螺杆菌阳性
质子泵抑制剂
序贯疗法
不同剂量
效果
Peptic ulcer
Helicobacter pylori-positive
Proton pump inhibitor
Sequential therapy
Different doses
Effect